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Aim. To compare the peri- and postoperative data between a hybrid minimally invasive esophagectomy (HMIE) and the
conventional Ivor Lewis esophagectomy. Methods. Retrospective comparison of perioperative characteristics, postoperative
complications, and survival betweenHMIE and Ivor Lewis esophagectomy. Results. 216 patients were included, with 160 procedures
performed with the conventional and 56 with the HMIE approach. Lower perioperative blood loss was found in the HMIE group
(600ml versus 200ml, 𝑝 < 0.001). Also, a higher median number of lymph nodes were harvested in the HMIE group (median
28) than in the conventional group (median 23) (𝑝 = 0.002). The median length of stay was longer in the conventional group
compared to the HMIE group (11.5 days versus 10.0 days, 𝑝 = 0.03). Patients in the HMIE group experienced fewer grade 2
or higher complications than the conventional group (39% versus 57%, 𝑝 = 0.03). The rate of all pulmonary (51% versus 43%,
𝑝 = 0.32) and severe pulmonary complications (38% versus 18%, 𝑝 = 0.23) was not statistically different between the groups.
Conclusions. The HMIE was associated with lower intraoperative blood loss, a higher lymph node harvest, and a shorter hospital
stay. However, the inborn limitations with the retrospective design stress a need for prospective randomized studies. Registration
number is DRKS00013023.
1. Introduction
Surgery is the treatment of choice for resectable tumors in
the distal esophagus and at the gastroesophageal junction.
However, the surgical procedure is associated with a high
incidence of postoperative morbidity and mortality with the
latter ranging from 2 to 10% [1, 2]. In order to minimize
postoperative morbidity and mortality, minimally invasive
esophagectomy has been implemented. Minimally invasive
surgery diminishes the surgical trauma [3], reduces blood
loss and overall hospital stay [4–6], and has comparable
oncological results to open surgery [7, 8]. Nevertheless,
the conventional minimally invasive surgical methods are
challenged by technical aspects, such as two-dimensional
view with lack of depth perceptions, long and rigid instru-
ments, and uncomfortable positions for the surgeon [9].
These limitations are less prominent with the implementa-
tion of robot-assisted esophagectomy, which allows three-
dimensional view and improved articulation of instruments
with seven degrees of freedom [10]. Still, data on the clinical
effects of robot-assisted esophagectomy are scarce with only
few studies published [11, 12].
At our department, a hybrid minimally invasive Ivor
Lewis esophagectomy (HMIE), with robot-assisted laparo-
scopic access to the abdominal cavity and conventional
thoracotomy, was implemented during spring 2013. Accord-
ingly, both the HMIE and the conventional Ivor Lewis
esophagectomy have been standard procedures since the
implementation of the robot-assisted procedure. The aim of
this study was to compare the intra- and postoperative data
between the two surgical approaches.
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2. Materials and Methods
2.1. Patients. Data from all patients operated for adenocar-
cinoma in the distal esophagus, at a tertiary referral center
in the period from January 1, 2013, to June 1, 2015, were
included in the analysis. The patients were retrospectively
identified by using the operation codes of The Nordic
Medico-Statistical Committee related to resection of distal
EC [13].The presented results from theHMIE group included
the learning curve. Initially the operating Robot (daVinci
Si System, Intuitive Surgical Inc., Sunnyvale, CA, USA) was
available for 1 day a week; however, resections for distal EC
were performed 3 days weekly; thus patients were allocated
randomly according to the operation day. However patients
that were initially allocated to the HMIE procedure were
disqualified if obese (BMI ≥ 35), had a history of previous
open abdominal surgery, or were suspected for having a T4-
tumor. After two months, the restriction regarding obesity
was revised due to good experience with borderline obese
cases.
2.2. Preoperative Management. All patients followed a stan-
dard program after referral to our center. Accordingly,
the patients underwent a confirmatory esophagogastroduo-
denoscopy followed by a contrast enhanced thoracoabdomi-
nal computed tomography (CT) scan (or positron emission
tomography- (PET-) CT scan if indicated). These exami-
nations were supplemented by an ultrasound examination
of the neck and a pulmonary function test, prior to a
multidisciplinary conference with the presence of specialists
within the fields of surgery, oncology, radiology, pathology,
and nuclear medicine. If a patient was considered eligible for
surgery, a diagnostic laparoscopy was performed to evaluate
the resectability. Prior to definitive surgery, patients with
adenocarcinoma were referred for perioperative oncological
adjuvant chemotherapy according to the MAGIC-regimen
[14].
2.3. Surgical Procedures. The conventional transthoracic
esophagectomy started with upper laparotomy. Hereafter
resectability was again evaluated by ruling out any signs
of distant or nonresectable spread. The gastroesophageal
junction and the hiatus is hereafter exposed by division of
the gastrohepatic and the phrenoesophageal ligaments. The
stomach is mobilized at the greater curvature by division
of the short gastric vessels and the gastrocolic ligament
under the consideration of the right gastroepiploic artery.The
stomach is lifted up and the left gastric vessels are identified
and divided. The stomach is then mobilized from the lesser
curvature to the right gastric artery. This step is followed by
Kocher Maneuver. The stomach conduit was then prepared
and a pyloromyotomy was performed.
In contrast, the robot-assisted laparoscopy started with
insufflation (12mmHg) with the patient in a supine position,
followed by mobilization of the stomach, lymphadenectomy,
and division of arteries with the patient in a 13-degree
head-up tilt position, as described for the open procedure.
After the closure of abdomen (conventional procedure)
and desufflation (robot-assisted laparoscopy), the thoracic
surgical procedurewas identical in both groups; a right thora-
cotomy at the sixth intercostal space to remove the tumor en
bloc along with mediastinal, subcarinal, and paraesophageal
lymph nodes (D1+ lymphadenectomy). After resection of
the tumor, gastric continuity was reestablished between the
esophagus and the remnant corpus part of the stomach,
and the surgery was concluded with the placement of a
nasogastric tube and a chest tube.
2.4. Postoperative Management. All patients followed a stan-
dardized postoperative care regimen and were mobilized
from day one. Pain was managed using epidural analgesia
until the postoperative day three, and patients were individu-
ally supplemented with paracetamol, tramadol, or morphine
if indicated. During the first week after surgery, patients
followed a strict nil-by-mouth regimen and were instead
supplied with intravenous nutrition. At the 7th postoperative
day, an X-ray with orally administered contrast swallow was
performed to evaluate the integrity of the anastomosis, with
reintroduction of liquid oral intake if no sign of anastomotic
leakage was detected.
2.5. Study Design. The present study was a retrospective,
nonrandomized, single center evaluation, comparing the
conventional with the HMIE. In cases where the HMIE were
converted into a conventional open procedure, the results
were presented as a conventional procedure.
As this was a retrospective study assessing the treatment
quality no ethical approval was required. All patient sensitive
data were treated anonymously and were not directly trans-
ferable to the individual patient.
2.6. Patient Data Registration. All preoperative data regard-
ing demography, comorbidities, height, and weight were
retrieved from the electronic patient records. Also, data
regarding postoperative morbidity and mortality were reg-
istered according to the Clavien-Dindo classification [15]
(Table 1), followed by the calculation of the comprehensive
complication index (CCI) score [16] using the online tool
available at http://www.assessurgery.com/about cci-calcula-
tor/. All events were recorded individually by two investi-
gators and disagreements were settled by discussion within
the group. Anastomotic insufficiencywas confirmed by either
contrast enhanced CT scan/X-ray or by endoscopy and was
graded according to Svendsen et al. [17].
2.7. Statistics. Descriptive statistics for continuous variables
are presented as median (min., max.) and dichotomous
variables are presented by the absolute number and the
percentage of positives. Continuous variables were compared
using Mann-Whitney U test, while 𝜒2-test was used for
categorical variables.
The statistical analyses were performed using the SPSS-
software (IBM SPSS statistics for Windows, Version 22.0.
Armonk, NY). 𝑝 values < 0.05 were considered significant.
The comparison of long-term survival between groups was
conducted through a Log-Rank test.
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Table 1: Clavien-Dindo classification of postoperative complications.
Grade I
Any deviation from the normal postoperative course without the need for pharmacological treatment or
surgical, endoscopic, and radiological interventions. Allowed therapeutic regimens are drugs as antiemetics,
antipyretics, analgetics, diuretics, electrolytes, and physiotherapy. This grade also includes wound infections
opened at the bedside.
Grade II Requiring pharmacological treatment with drugs other than such allowed for grade I complications. Bloodtransfusions and total parenteral nutrition are also included.
Grade III Requiring surgical, endoscopic, or radiological intervention.
(i) IIIa Intervention not under general anesthesia.
(ii) IIIb Intervention under general anesthesia
Grade IV Life-threatening complications (including CNS complications) requiring IC/ICU management.
(i) IVa Single organ dysfunction (including dialysis).
(ii) IVb Multiorgan dysfunction.
Grade V Death of the patient.
3. Results
During the period of January 1, 2013, to June 1, 2015, a total of
216 patients were included in the statistical analysis, with 160
procedures performed with the conventional approach and
56 with the HMIE approach. Two cases were converted due
to obesity and severe adhesions.
There were no differences regarding age and gender
distribution, bodymass index (BMI), or ASA-scores between
the two groups (Table 2).
A significantly lower total blood loss was found in the
HMIE group compared to the conventional group (600ml
versus 200ml, 𝑝 < 0.001). Also, the median number of
harvested lymph nodes was significantly higher in the HMIE
group (median 28) than in the conventional group (median
23) (𝑝 = 0.002). In contrast, neither the time of general
anaesthesia, operating time, nor the total procedure time was
statistically different between the groups.
The median length of hospital stay was significantly
longer in the conventional group compared to the HMIE
group (11.5 days versus 10.0 days, 𝑝 = 0.03). There were
no differences in postoperative complications between the
conventional and the HMIE group regarding the proportion
of patients experiencing one or more complications of grade
I or higher (76% versus 65%, 𝑝 = 0.12), just as no
difference in CCI score (12.2 versus 20.9, (𝑝 = 0.12)) was
found. The proportion of patients in the HMIE group which
experienced one or more complications of grade II or higher
was significantly lower than in the conventional group (39%
versus 57%, 𝑝 = 0.03). The rate of anastomotic insufficiency
was identical (7%) (𝑝 = 1.00), and there were no significant
differences regarding the 30- and 90-day mortality between
the groups.
The rate of all pulmonary complications is shown in
Table 3 and shows no statistical differences between the two
groups, both regarding the sum of pulmonary complications
and when looking isolated at the severe pulmonary com-
plications. However there was a trend towards fewer severe
complications in the HMIE groups, but this finding was not
statistically significant.
There was no statistically significant difference between
the two groups regarding the long-term survival (𝑝 = 0.7).
4. Discussion
In the present study, we found that patients operated with
the HMIE approach had a lesser surgical blood loss, had
more lymph nodes harvested, and had a shorter hospital stay
compared to patients undergoing conventional Ivor Lewis
esophagectomy. Furthermore, the HMIE group experienced
fewer grade ≥II complications than the conventional group.
The abovementioned perioperative benefits regarding
blood loss and lymph node harvest related to the HMIE
approach could reflect that the robot assistance offers a more
precise and refined dissection phase compared to the conven-
tional approach. This has benefits, as it has been proposed
that blood transfusions are associated to a poorer long-term
outcome in cancer patients [18] and are thus important to
avoid. The impact of the extent of lymph node resection on
long-term survival is much debated. Some papers advocate
that the number of removed lymph nodes is an independent
prognostic marker [19]. Other reports state that increasing
the number of harvested lymph nodes does not per se offer
any improvement in the survival [20]. However, the number
of metastatic nodes removed and increasing positive-to-
negative node ratio were strongly negatively associated to
survival [20]. Thus an increased lymph node harvest leads to
a better staging. In the present series the increased number of
harvested lymph nodes in the HMIE group did not translate
into an improved survival, indicating that there is little or
no impact on survival. The presented number of harvested
lymph nodes in this series is the total amount, and the lymph
nodes therefore originate fromboth the thorax and abdomen.
As the thoracic approach was identical it is plausible that the
difference in lymph node harvest was due to the different
abdominal approaches.
The findings, regarding the postoperative complications,
were not entirely clear. No difference in the CCI score
between the groups was found; however, a significantly lower
proportion of the patients in the HMIE group experienced
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Table 2: Comparison of pre-, peri-, and postoperative data between cohorts.
Conventional (𝑛 = 160) HMIE (𝑛 = 56) 𝑝 value
Age∗ 65 (28–88) 66 (39–86) 0.65
Gender
(i) Male 125 (78%) 50 (88%)
(ii) Female 35 (22%) 6 (12%) 0.12
BMI∗ 26.6 (15.6–43.7) 25.8 (18.8–31.2) 0.19
ASA-score
(i) ASA 1 (%) 41 (26%) 17 (30%) 0.73
(ii) ASA 2 (%) 80 (50%) 28 (50%) 1
(iii) ASA 3 (%) 39 (24%) 12 (21%) 0.72
(iv) ASA 4 (%) 0 (0%) 1 (2%)
Operating time∗ (minutes) 248 (100–420) 232 (174–800) 0.2
Blood loss∗ (ml) 600 (100–4400) 200 (50–1970) <0.001
Harvested lymph nodes∗ 23 (11–60) 28 (15–61) 0.002
Length of stay∗ (days) 11.5 (8–101) 10 (8–69) 0.03
CCI-score 20.9 (0–100) 12.2 (0–100) 0.22
Complications∗∗
(i) ≥Grade I complications (%) 122 (76%) 37 (65%) 0.12
(ii) ≥Grade II complications (%) 91 (57%) 22 (39%) 0.02
(iii) ≥Grade III complications (%) 51 (32%) 14 (25%) 0.32
Anastomotic insufficiency 11 (7%) 4 (7%) 1
30-day mortality (%) 3 (2%) 0 (0%) 0.57
90-day mortality (%) 5 (3%) 3 (5%) 0.43
HMIE: hybrid minimally invasive esophagectomy; CCI: comprehensive complication index. These scores are generated from http://www.assessurgery.com/
about cci-calculator/; ∗continuous covariates are presented with median and minimum and maximum values; ∗∗complications are graded according to the
Clavien-Dindo score. The numbers represents the proportion of patients experiencing one or more complications of at least the grade indicated in the table.
Table 3: Pulmonary complications.
Conventional (𝑛 = 160) HMIE (𝑛 = 56) 𝑝 value
All pulmonary complications 51% (81/160) 43% (24/56) 0.32
Severe pulmonary complications∗ 38% (41/160) 18% (10/56) 0.24
∗Severe respiratory complications are defined as grade III or higher on the Clavien-Dindo score.
one or more grade II complications, compared to the
conventional group in the current study. These findings
are in accordance with the available literature, where the
majority of studies report no major differences between
the minimally invasive and conventional approaches [21].
Accordingly, some studies report fewer complications with
a minimally invasive approach [22, 23], but reports have
also indicated that the minimally invasive approach was
associated with a higher frequency of acute reoperation
[24]. In this study, there was no difference in the pattern
of grade II complications between the groups, and thus
no apparent explanation for this difference. There was no
difference between groups regarding the more severe grade
≥III complications.
In general, the quantification of postoperative compli-
cations is semiquantitative by nature, making direct com-
parison between studies difficult. The Clavien-Dindo grad-
ing system does offer some standardization, but different
interpretations of the grading system, especially in the low-
grade complication range, are likely to occur. Due to these
difficulties in getting an objectivemeasure, surrogatemarkers
for the quantification of the complexity of the postoperative
course could be used. One such parameter is the total length
of hospital stay, which in this study was shorter in the HMIE
group compared to the conventional group. This fact may
have important economic implications, as a shortening of
the admission time may level out the higher costs associated
with the robot-assisted procedure. This benefit has been
reported for gynecological and urological cancers [25, 26].
More interestingly, it is conceivable that the length of stay and
rate of postoperative complications may be further reduced
by introducing MIS in the thoracic part of the procedure.
Currently, no consensus regarding the role of MIS in the
surgical treatment of upper gastrointestinal cancers exists. A
consensus is difficult to define, since the surgical strategies
for treating upper gastrointestinal cancers cover a very
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heterogeneous group of procedures, both regarding the type
of access, that is, laparoscopy and robot-assisted laparoscopy,
and whether or not these modalities should be applied in
the abdomen and/or the thorax. Furthermore, the study
designs in previous studies investigating the role of MIS have
been suboptimal, with the vast majority being retrospective
with small patient volume and with great variation of the
surgical techniques among the studies. This aspect is also
a limitation in the present study, as this was conducted
retrospectively at a single center. This only highlights the
need for large prospective randomized trials. Such trials
have been registered [7, 27, 28]. Trials comparing the HMIE
with the conventional Ivor Lewis esophagectomy especially
are relevant due to the similar surgical techniques between
the studies [27, 29]. Messager et al. showed significantly
reduced perioperative mortality when comparing the HMIE
with the conventional procedure [29]. This feat was achieved
without a higher rate of reoperation, which had been a
concern in previous reports. However, the rate and type of
postoperative complications were not reported in the study
[29]. Data from the MIRO-trial [27] do show that the rate
of pulmonary complications was significantly decreased in
the hybrid group. We were unable to reproduce these results;
however, there was a trend towards fewer severe pulmonary
complications in the HMIE group. Most significantly we
found that the length of staywas reduced for theHMIE group.
Thefindings fromour study in combinationwith randomized
HMIE studies indicate that HMIE could offer important
advantages and may be the future standard surgical strategy
for patients with malignant tumors in the distal esophagus.
5. Conclusion
This study shows that HMIE was associated with a signifi-
cantly reduced intraoperative blood loss, a higher number of
harvested lymph nodes, and a shorter hospital stay. Whether
this is solely due to the less invasiveness of the HMIE
compared to conventional Ivor Lewis esophagectomy needs
to be investigated further and the possible advantages must
be confirmed in a prospective randomized setting.
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